Prolonged Treatment with Isoproterenol Causes a Loss of Myocardial Gsα mRNA Expression

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 25, Issue 9, 2003, Pages 723-726

  Miyamoto, Atsushi ^a   Ohshika, H ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiac ventricle; Desensitization; Gs mRNA expression; Inotropic effect; Isoproterenol; Male Wistar rat

Indexed keywords

ASTHPUL; ISOPRENALINE; MESSENGER RNA; PROPRANOLOL; SODIUM CHLORIDE; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; DESENSITIZATION; DOSE RESPONSE; DOSE TIME EFFECT RELATION; GENE EXPRESSION; HEART MUSCLE; HEART VENTRICLE; INOTROPISM; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HEART; ISOPROTERENOL; MALE; MYOCARDIUM; ORGAN SIZE; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 0346502203     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2003.25.9.793340     Document Type: Article

References (16)

1. Hadcock, J.R., Ros, M., Watkins, D.C., Malbon, C.C. Cross-regulation between G-protein-mediated pathways. Stimulation of adenylyl cyclase increases expression of the inhibitory G-protein, Giα2. J Biol Chem 1990, 265: 14784-90.
2. Hadcock, J.R., Malbon, C.C. Agonist regulation of gene expression of adrenergic receptors and G proteins. J Neurochem 1993, 60: 1-9.
3. Chen, L., Vatner, D.E., Vatner, S.F., Hittinger, L., Homcy, C.J. Decreased Gsα mRNA levels accompany the fall in Gs and adenylyl cyclase activities in compensated left ventricular hypertrophy. In heart failure, only the impairment in adenylyl cyclase activation progresses. J Clin Invest 1991, 87: 293-8.
4. Eschenhagen, T., Mende, U., Diederich, M. et al. Long term β-adrenoceptor-mediated up-regulation of Giα and G(o) α mRNA levels and pertussis toxin-sensitive guanine nucleotide-binding proteins in rat heart. Mol Pharmacol 1992, 42: 773-83.
5. Eschenhangen, T. G proteins and the heart. Cell Biol Int 1993, 17: 723-49.
6. Neers, E.J., Clapham, D.E. Trends Cardiovasc Med 1992, 2: 6-11.
7. Ungerer, M., Böhm, M., Elce, J.S., Erdmann, E., Kohse, M.J. Altered expression of β-adrenergic receptor kinase and β 1-adrenergic receptors in the failing human heart. Circulation 1993, 87: 454-63.
8. Kimura, H., Miyamoto, A., Ohshika, H. Down-regulation of β-adrenoceptors and loss of Gsct subunit levels in ventricular myocardium of rats treated with isoproterenol. Life Sci 1993, 53: PL171-6.
9. Miyamoto, A., Ohshika, H. Cellular and molecular mechanisms of cardiovascular aging. Molecular pharmacological implications. Ann NY Acad Sci 1996, 786: 283-93.
10. Miyamoto, A., Kawana, S., Kimura, H., Ohshika, H. Impaired expression of Gsa protein mRNA in rat ventricular myocardium with aging. Eur J Pharmacol 1994, 266: 147-54.
11. Chomczynski P., Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162: 156-9.
12. Ma, Z., Miyamoto, A., Lee, S.S. Role of altered β-adrenoceptor signal transduction in the pathogenesis of cirrhotic cardiomyopathy in rats. Gastroenterology 1996, 110: 1191-8.
13. Milligan, G., Green, A. Agonist control of G-protein levels. Trends Pharmacol Sci 1991, 12: 207-9.
14. Milligan, G. Agonist regulation of cellular G protein levels and distribution: Mechanisms and functional implications. Trends Pharmacol Sci 1993, 14: 413-8.
15. Mullaney, I., Dodd, M.W., Buckley, N., Milligan, G. Agonist activation of transfected human M1 muscarinic acetylcholine receptors in CHO cells results in down-regulation of both the receptor and the α subunit of the G-protein Gq. Biochem J 1993, 289: 125-31.
16. Schnabel, P., Böhm, M. Heterotrimeric G proteins in heart disease. Cell Signal 1996, 8: 413-23.